01—Abstract
Summary
Summary of the 8-K filed January 8, 2010. Cited figures are marked; the original filing is the authoritative source.
This Form 8-K filing by Procter & Gamble (PG) on January 8, 2010, provides investors with crucial pro forma historical financial data for the three months ended December 31, 2008.
The report details significant changes to the company's segment reporting structure, effective July 1, 2009, and presents the divestiture of its global pharmaceuticals business as a discontinued operation. These adjustments aim to offer a clearer view of the company's ongoing core businesses and how they are now categorized. Key financial adjustments include the reclassification of certain brands between the Beauty and Grooming segments, and the exclusion of the now-sold pharmaceuticals business.
Investors can use this pro forma information to better understand the underlying performance of Procter & Gamble's continuing operations, aiding in the comparative analysis of historical results against the new reporting structure. The filing ensures transparency regarding these organizational and operational changes, which are important for evaluating the company's future strategic direction and financial health.
02—Key points
Key Highlights
- Pro forma historical financial results for the three months ended December 31, 2008, are presented to reflect changes in segment reporting and the divestiture of the pharmaceuticals business.
- Procter & Gamble updated its Global Business Unit (GBU) structure effective July 1, 2009, with specific reallocations of brands between the Beauty and Grooming segments.
- Female blades and razors moved from Grooming to Beauty GBU.
- Certain male-focused brands (e.g., Old Spice, Gillette personal care) moved from Beauty to Grooming GBU.
- The Beauty GBU has been renamed the Beauty and Grooming GBU.
- The global pharmaceuticals business, sold on October 30, 2009, for $2.9 billion, is presented as discontinued operations.
- The pro forma net sales for the three months ended December 31, 2008, were $19,763 million, compared to the as-reported $20,368 million, reflecting the impact of the pharmaceuticals divestiture.
03—Questions
Frequently Asked Questions
What is the main purpose of this 8-K filing?
The main purpose of this 8-K filing is to provide investors with pro forma historical financial data for the three months ended December 31, 2008. This data reflects the company's updated segment reporting structure and the presentation of its formerly divested pharmaceuticals business as discontinued operations, offering a clearer view of ongoing business performance.
How have Procter & Gamble's business segments changed?
Procter & Gamble changed its segment reporting structure effective July 1, 2009. The Beauty GBU was renamed the Beauty and Grooming GBU. Female blades and razors were moved from the Grooming segment to the Beauty segment, while certain male-focused brands like Old Spice and Gillette personal care moved from the Beauty segment to the Grooming segment.
What is happening with the pharmaceuticals business?
Procter & Gamble sold its global pharmaceuticals business to Warner Chilcott plc on October 30, 2009, for $2.9 billion. As a result, the financial results of this business are now presented as discontinued operations in the company's financial statements, meaning they are excluded from continuing operations and segment results.
How does the pro forma data differ from the reported data for the quarter ended December 31, 2008?
The pro forma data for the three months ended December 31, 2008, shows net sales of $19,763 million, gross margin of $9,964 million, and net earnings from continuing operations of $2,813 million. This compares to the as-reported figures of $20,368 million in net sales, $10,518 million in gross margin, and $2,962 million in net earnings from continuing operations. The differences are primarily due to the exclusion of the pharmaceuticals business from continuing operations in the pro forma presentation and adjustments to segment allocations.
04—Continue